Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Laventatug

Copy Product Info
🥰Excellent

Synonyms:

Catalog No. T9901A-856 Copy Product Info
🥰Excellent
Laventatug is a humanized monoclonal antibody targeting human SLC39A6. By specifically binding to SLC39A6, it disrupts the transport process of zinc ions within cells, thereby exhibiting antitumor activity. Laventatug holds potential for cancer research.
Laventatug
Cas No. 3009829-91-5
Pack SizePriceUSA StockGlobal StockQuantity
1 mgInquiry4-6 weeks4-6 weeks
5 mgInquiry4-6 weeks4-6 weeks
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Laventatug is a humanized monoclonal antibody targeting human SLC39A6. By specifically binding to SLC39A6, it disrupts the transport process of zinc ions within cells, thereby exhibiting antitumor activity. Laventatug holds potential for cancer research.
Reactivity
Human
Application
FACS
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
TargetSLC39A6
Chemical Properties
Cas No.3009829-91-5
Storage & Solubility Information
StorageStore at low temperature -20°C for 1 year Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion
Related Tags: